77.36
Overview
News
Price History
Option Chain
Financials
Why MET Down?
Discussions
Forecast
Dividend History
Metlife Inc stock is traded at $77.36, with a volume of 4.30M.
It is down -1.94% in the last 24 hours and down -1.23% over the past month.
MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: Group Benefits, Retirement and Income Solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Holdings (products in run-off). Group Benefits and RIS are US-based, contributing to around 48% of the firm's 2024 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 13% of 2024 earnings. The EMEA and MetLife Holdings segments contributed around 4% and 10% of 2024 earnings, respectively.
See More
Previous Close:
$78.89
Open:
$79.04
24h Volume:
4.30M
Relative Volume:
1.17
Market Cap:
$50.69B
Revenue:
$77.08B
Net Income/Loss:
$3.40B
P/E Ratio:
16.42
EPS:
4.711
Net Cash Flow:
$15.15B
1W Performance:
+2.71%
1M Performance:
-1.23%
6M Performance:
+1.04%
1Y Performance:
-6.49%
Metlife Inc Stock (MET) Company Profile
Name
Metlife Inc
Sector
Industry
Phone
212-578-5500
Address
200 PARK AVENUE, NEW YORK, NY
Compare MET vs AFL, MFC, PUK, PRU
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
MET
Metlife Inc
|
77.36 | 51.70B | 77.08B | 3.40B | 15.15B | 4.711 |
|
AFL
Aflac Inc
|
115.88 | 60.30B | 17.13B | 3.65B | 2.57B | 6.8862 |
|
MFC
Manulife Financial Corp
|
35.81 | 63.53B | 42.06B | 4.30B | 21.81B | 2.2533 |
|
PUK
Prudential Plc Adr
|
29.78 | 40.46B | 21.69B | 3.60B | 1.36B | 2.5833 |
|
PRU
Prudential Financial Inc
|
104.15 | 36.83B | 59.30B | 3.73B | 5.27B | 10.00 |
Metlife Inc Stock (MET) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-06-26 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-16-25 | Initiated | Mizuho | Outperform |
| Sep-19-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-16-25 | Initiated | Wolfe Research | Outperform |
| Jan-23-25 | Initiated | BMO Capital Markets | Market Perform |
| Oct-09-24 | Initiated | TD Cowen | Buy |
| Sep-05-24 | Initiated | Barclays | Overweight |
| Jan-08-24 | Upgrade | Goldman | Neutral → Buy |
| Nov-17-23 | Resumed | Barclays | Overweight |
| Oct-05-23 | Initiated | Deutsche Bank | Hold |
| Sep-14-23 | Upgrade | Jefferies | Hold → Buy |
| Jan-09-23 | Downgrade | Goldman | Buy → Neutral |
| Dec-09-22 | Downgrade | Jefferies | Buy → Hold |
| Sep-22-22 | Initiated | Raymond James | Mkt Perform |
| Jun-23-22 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| May-24-22 | Initiated | Citigroup | Buy |
| Jan-26-22 | Initiated | Jefferies | Buy |
| Jan-21-22 | Initiated | Wolfe Research | Peer Perform |
| Jan-12-22 | Reiterated | UBS | Buy |
| Jan-05-22 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-03-21 | Initiated | Goldman | Buy |
| Apr-21-21 | Initiated | UBS | Buy |
| Jan-06-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-08-20 | Upgrade | Citigroup | Neutral → Buy |
| Dec-04-20 | Initiated | Goldman | Neutral |
| Nov-17-20 | Initiated | Barclays | Overweight |
| Jun-01-20 | Resumed | BofA/Merrill | Buy |
| Mar-16-20 | Upgrade | Citigroup | Sell → Neutral |
| Jan-07-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jul-16-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Mar-19-19 | Downgrade | Sandler O'Neill | Buy → Hold |
| Jan-16-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jan-02-19 | Upgrade | Sandler O'Neill | Hold → Buy |
| Jun-04-18 | Downgrade | Goldman | Buy → Neutral |
| Apr-25-18 | Initiated | Credit Suisse | Outperform |
| Mar-26-18 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Jan-02-18 | Initiated | Deutsche Bank | Hold |
| Nov-10-17 | Downgrade | Sandler O'Neill | Buy → Hold |
| Nov-03-17 | Reiterated | RBC Capital Mkts | Outperform |
| May-25-17 | Upgrade | FBR & Co. | Mkt Perform → Outperform |
| Mar-06-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jan-26-17 | Initiated | Citigroup | Sell |
| Dec-09-16 | Downgrade | Standpoint Research | Buy → Hold |
View All
Metlife Inc Stock (MET) Latest News
Growing Retirement Fears Put MetLife’s Guaranteed Income Strategy In Focus - Yahoo Finance
Mizuho Adjusts Price Target on MetLife to $100 From $102, Maintains Outperform Rating - marketscreener.com
ProShare Advisors LLC Sells 13,189 Shares of MetLife, Inc. $MET - MarketBeat
Critical Illness Insurance Market to Reach USD 659.84 Billion by 2033, Growing at 9.01% CAGR – SNS Insider - GlobeNewswire Inc.
Evercore ISI Adjusts Price Target for MetLife (MET) as In-Line R - GuruFocus
Evercore ISI Adjusts Price Target on MetLife to $95 From $97, Maintains In Line Rating - marketscreener.com
The Bull Case For MetLife (MET) Could Change Following Rising Revenue, Falling Earnings And Ongoing Buybacks - simplywall.st
5 Insightful Analyst Questions From MetLife's Q4 Earnings Call - Finviz
Precision Trading with Metlife Inc. (MET) Risk Zones - Stock Traders Daily
Candriam S.C.A. Sells 193,802 Shares of MetLife, Inc. $MET - MarketBeat
MetLife price target lowered to $95 from $97 at Evercore ISI - Investing.com India
Evercore ISI Cuts MetLife Price Target to $95 From $97 - marketscreener.com
Metlife study finds less than half of US workforce holistically healthy - InsuranceNewsNet
Half of Retirees Fear Running Out of Money as Pressures on U.S. Retirement Security Intensify, MetLife Research Finds - Business Wire
Compagnie Lombard Odier SCmA Has $13.57 Million Stock Position in MetLife, Inc. $MET - MarketBeat
Providence Capital Advisors LLC Takes Position in MetLife, Inc. $MET - MarketBeat
Versor Investments LP Lowers Holdings in MetLife, Inc. $MET - MarketBeat
Signature Estate & Investment Advisors LLC Has $876,000 Stock Holdings in MetLife, Inc. $MET - MarketBeat
MetLife, Inc. $MET Stock Position Decreased by Applied Finance Capital Management LLC - MarketBeat
1 Insurance Stock with Impressive Fundamentals and 2 Facing Headwinds - Finviz
MetLife Slips 3% This Week: Here’s Why Analysts Still Sees $104.83 Fair Value - TIKR.com
Jefferies Adjusts MetLife Price Target to $96 From $101, Maintains Buy Rating - marketscreener.com
MetLife UK pays out £252mn in employee benefits - FT Adviser
Risk Recap: Is MetLife Inc a momentum stockMarket Sentiment Summary & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Diamond Hill Capital Management Inc. Has $329.62 Million Position in MetLife, Inc. $MET - MarketBeat
Metlife (MET) Gets a Buy from Barclays - The Globe and Mail
MetLife Stock: Limited Upside Given VII Reliance (NYSE:MET) - Seeking Alpha
MetLife, Inc. (NYSE:MET) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
MetLife Q4 Earnings Call Highlights - MarketBeat
MetLife, Inc. (NYSE:MET) Q4 2025 Earnings Call Transcript - Insider Monkey
Research Alert: CFRA Keeps Buy Opinion On Shares Of Metlife, Inc. - 富途牛牛
‘There’s no demand for labor’ – MetLife’s Drew Matus - Seeking Alpha
MetLife stock outlook: Is Wall Street bullish or bearish? - MSN
Piper Sandler Adjusts Price Target on MetLife to $81 From $84, Maintains Neutral Rating - marketscreener.com
Wolfe Research Adjusts Price Target on MetLife to $89 From $91, Maintains Outperform Rating - marketscreener.com
MetLife Q4 2025 slides: Earnings exceed targets as investment management soars By Investing.com - Investing.com South Africa
Is MetLife Inc the Safest Flex on Wall Street Right Now? Real Talk on MET - AD HOC NEWS
MetLife Broadens Upwise Reach Through Nayya and Workday Deal - MSN
Envestnet Asset Management Inc. Sells 448,986 Shares of MetLife, Inc. $MET - MarketBeat
MetLife Reports Strong 2025 Results and Growth Momentum - The Globe and Mail
MetLife Inc (MET) Q4 2025 Earnings Call Highlights: Strong Finan - GuruFocus
MetLife Inc (MET) Q4 2025 Earnings Call Highlights: Strong Financial Performance and Strategic ... By GuruFocus - Investing.com Canada
6 Analysts Have This To Say About MetLife - Benzinga
MetLife Tops Fortune List As Investors Weigh Mixed Earnings Picture - Yahoo Finance
MetLife Q4 Earnings Beat Estimates on Increasing Volumes - Nasdaq
Barclays Adjusts Price Target on MetLife to $92 From $90, Maintains Overweight Rating - marketscreener.com
MetLife (MET) Reports Strong 2025 Earnings and Strategic Progres - GuruFocus
Earnings call transcript: MetLife Q4 2025 earnings beat EPS forecasts By Investing.com - Investing.com Nigeria
Higher Private Equity Returns Help Fuel MetLife Profit Jump - Bloomberg.com
Earnings call transcript: MetLife Q4 2025 earnings beat EPS forecasts - Investing.com
UBS Adjusts Price Target on MetLife to $98 From $94, Maintains Buy Rating - marketscreener.com
Metlife Inc Stock (MET) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):